World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases Press Releases - Lifestyle

MGI Tech and Shanghai AI Laboratory Unveil ProtoPilot and BioLab Bench, Pioneering Physical AI for Life Sciences

Cision PR Newswire by Cision PR Newswire
July 6, 2026
in Press Releases - Lifestyle
Reading Time: 4 mins read
0
Share on FacebookShare on Twitter

SHENZHEN, China, July 5, 2026 /PRNewswire/ — MGI’s subsidiary, Genoria AI, in collaboration with the Shanghai Artificial Intelligence Laboratory, today announced the launch of two breakthrough innovations that close the gap between digital intelligence and physical execution in biology: ProtoPilot, a self-evolving multi-agent system driven by real-world laboratory scenarios; and BioLab Bench, the industry’s first comprehensive evaluation framework that assesses AI agents from user requirements to executable device operations.

Together, these innovations establish a new paradigm—Physical AI for life sciences—where intelligent agents do not merely generate textual answers but translate experimental intent into physically executable, verifiable, and reproducible actions on automated lab platforms. The research behind it was published as a preprint on arXiv (arXiv:2606.31763) in June 2026.

ProtoPilot: A Full-Chain Agent System That Learns from Failure

ProtoPilot is a self-evolving multi-agent system that covers the entire experimental lifecycle:
Design2Protocol → Protocol2Code → Device Execution → Wet-Lab Feedback

It learns from failure. When a PCA assembly step failed, ProtoPilot diagnosed the issue (antibiotic resistance screening failure) and autonomously regenerated a corrected protocol—proving true Physical AI is here.

ProtoPilot achieved 52.38% on ProtocolQA

On ProtocolQA, one of the most representative public benchmarks for evaluating AI experimental reasoning capabilities (built by AI4S leader Future House):

  • GPT-5.6-sol scored 43.5%
  • Human expert level stands at 54%
  • ProtoPilot achieved 52.38% —approaching expert-level performance!
BioLab Bench: The First Real-Task Evaluation System for Life Science Agents

BioLab Bench sets a new industry standard. It’s the first evaluation system that measures not just “correct answers,” but whether an agent can actually execute tasks on real automation equipment.

BioLab Bench

Key features include:

  • Real-World Task Coverage: BioLab Bench spans from fundamental operations to complex multi-step workflows, stratified across three difficulty levels (L1–L3).
  • Full-Chain Assessment: Rather than merely checking whether an agent generates a plausible protocol, BioLab Bench evaluates each step—intent interpretation, protocol design, device-agnostic SOP generation, device-specific SOP translation, machine code production, and successful execution gate verification.
  • Cross-Device Transferability: The benchmark can be deployed on different automated laboratory platforms to test whether an AI agent can comprehend experimental tasks and generate executable actions adapted to varying hardware configurations, thus assessing cross-device generalization capability.
Toward 7×24 Unattended Smart Laboratories

Moving forward, BioAgents will no longer improve solely through text-based training. Instead, through the PhysicalAI experimental loop, they will continuously accumulate real research tasks, automation operations, expert validations, failure cases, and wet-lab feedback. This massive corpus of physical experimental data will enable BioAgents to develop integrated reasoning, execution, and validation capabilities—ultimately powering 7×24 unattended intelligent laboratories.

Built on a Decade of Synergy Between AI and Biology

MGI’s exploration of AI dates back to 2019. In 2025, the team led by Dr. Yang Meng, Chief AI Officer of MGI, in collaboration with Professor Nattiya Hirankarn from Chulalongkorn University, published a paper in Nature Biomedical Engineering introducing “PrimeGen”—a dry–wet collaborative multi-agent system that integrated primer design, experimental validation, and automated workstation execution into a closed-loop workflow.

In April 2026, MGI established Genoria AI as a dedicated subsidiary focused on AI for Science (AI4S), with a mission to build dry–wet closed-loop infrastructure for the life sciences.

The new Physical AI initiative builds on MGI’s unique strengths in hardware-native advantages with deep integration across its automation platforms, and real-world deployment expertise gained from over 3,800 users globally.

“It reflects a different path from the pure compute race. While leading AI companies rely on scale compute to push the capabilities of general-purpose models, we take a different approach. Through agent scaling and closed-loop data engineering, we organize real-world tasks, device constraints, expert feedback, and wet-lab results into a training ground where AI continuously evolves.” Noted Dr. Yang Meng, now serving as CEO in Genoria AI.

About Genoria AI

Genoria AI, a subsidiary of MGI Tech, is an AI4S company building self-evolving labs to scale agentic discovery. Learn more: https://www.genoria.ai/en

About Shanghai Artificial Intelligence Laboratory

The Shanghai AI Laboratory was officially unveiled at the World AI Conference (WAIC) in July 2020 and positioned as a national-level new-type research institute. Our vision is to build a world-class AI laboratory, with pioneering contributions on original theories and key technologies. By gathering top talents from around the world and creating a stimulating and collaborative research environment, the Laboratory aims to conduct original and influential research, make fundamental contributions to basic theories, significantly advance the state of the art, and create remarkable impact on industry, healthcare, and education. Learn more: https://www.shlab.org.cn/

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/mgi-tech-and-shanghai-ai-laboratory-unveil-protopilot-and-biolab-bench-pioneering-physical-ai-for-life-sciences-302818081.html

SOURCE MGI Tech

Cision PR Newswire

Cision PR Newswire

Related Posts

Hexagon Agility receives significant order from Certarus for Mobile Pipeline modules to service data center demand

July 6, 2026

Hanon Systems Publishes White Paper on Next-Generation PFAS-Free Natural Refrigerant Technologies

July 6, 2026

Segway Powersports Opens First GCC Flagship Store in Riyadh with Launch of the Super Villain SX20T

July 6, 2026

Ascletis Submits Two IND Applications to the U.S. FDA for the Treatment of Obesity: ASC36 Once-Monthly Injection, a Peptide Amylin Receptor Agonist, and ASC36_35 FDC Once-Monthly Injection, a Co-Formulation of ASC36 Plus Peptide GLP-1R/GIPR Agonist ASC35

July 6, 2026

Hyundai Motor Brings Atlas Humanoid Robot to FIFA World Cup 2026™ in First-Ever Live Match Environment Robotics Integration

July 6, 2026

Celebrating Independence Day: Freedom to Enjoy Every Summer Moment With VARON Oxygen Concentrator Solutions

July 5, 2026

Popular News

  • Hexagon Agility receives significant order from Certarus for Mobile Pipeline modules to service data center demand

    0 shares
    Share 0 Tweet 0
  • MGI Tech and Shanghai AI Laboratory Unveil ProtoPilot and BioLab Bench, Pioneering Physical AI for Life Sciences

    0 shares
    Share 0 Tweet 0
  • Segway Powersports Opens First GCC Flagship Store in Riyadh with Launch of the Super Villain SX20T

    0 shares
    Share 0 Tweet 0
  • Hanon Systems Publishes White Paper on Next-Generation PFAS-Free Natural Refrigerant Technologies

    0 shares
    Share 0 Tweet 0
  • Ascletis Submits Two IND Applications to the U.S. FDA for the Treatment of Obesity: ASC36 Once-Monthly Injection, a Peptide Amylin Receptor Agonist, and ASC36_35 FDC Once-Monthly Injection, a Co-Formulation of ASC36 Plus Peptide GLP-1R/GIPR Agonist ASC35

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler